Dualitas Therapeutics Competitors: 10 Similar Biotech

Dualitas Therapeutics — investors and similar companies (54)

Companies comparable to Dualitas Therapeutics in Biotech, headquartered in South San Francisco, United States, ranked by how much of Dualitas Therapeutics's verified investor base they share. 150 of the companies below have at least one backer in common with Dualitas Therapeutics.

Overlap is computed from disclosed round records rather than from sector labels, so a company appears here because the same firms wrote cheques into both — the signal a founder benchmarking comparables or an investor mapping a sector actually wants. Each entry links to that company's own funding record and syndicate breakdown.

• Verified backers on record: 6
• Total disclosed funding: $65M
• Latest tracked round: Series A (2025-09-01)
• Sector: Biotech
• Headquarters: South San Francisco, United States

• Versant Ventures
• Qiming Venture Partners USA
• SV Health Investors
• Chugai Venture Fund
• Eli Lilly and Company
• Alexandria Venture Investments
• Autobahn Therapeutics — shares Alexandria Venture Investments
• Bright Peak Therapeutics — shares Versant Ventures +1
• Entact Bio — shares Qiming Venture Partners USA
• Gritstone bio — shares Versant Ventures
• Jaguar Gene Therapy — shares Eli Lilly and Company
• Capstan Therapeutics — shares Eli Lilly and Company +1
• Asher Bio — shares Alexandria Venture Investments
• AdvanCell — shares SV Health Investors
• Judo Bio — shares Alexandria Venture Investments
• Eyebiotech — shares SV Health Investors
• Superluminal Medicines — shares Eli Lilly and Company
• Affinia Therapeutics — shares Eli Lilly and Company
• Talaris Therapeutics — shares Qiming Venture Partners USA
• Xilio Therapeutics — shares SV Health Investors
• Nested Therapeutics — shares Versant Ventures
• Disc Medicine — shares Alexandria Venture Investments
• Myeloid Therapeutics — shares Alexandria Venture Investments
• Immunai — shares Alexandria Venture Investments
• Diasome Pharmaceuticals — shares Eli Lilly and Company
• Myricx Bio — shares Eli Lilly and Company
• VectivBio — shares Versant Ventures
• LEXEO Therapeutics — shares Alexandria Venture Investments
• Aerami Therapeutics — shares Versant Ventures
• Precede Biosciences — shares Alexandria Venture Investments
• Pipeline Therapeutics — shares Versant Ventures
• Invaio Sciences — shares Alexandria Venture Investments
• Codiak Biosciences — shares Alexandria Venture Investments
• Senda Biosciences — shares Alexandria Venture Investments
• Tubulis — shares Versant Ventures
• Matchpoint Therapeutics — shares Alexandria Venture Investments
• Ajax Therapeutics — shares Eli Lilly and Company
• Korro Bio — shares Qiming Venture Partners USA
• Tome Biosciences — shares Alexandria Venture Investments
• Delfi Diagnostics — shares Eli Lilly and Company
• Nouscom — shares Versant Ventures
• OrsoBio — shares Eli Lilly and Company
• Axonis Therapeutics — shares Alexandria Venture Investments
• Crystalys Therapeutics — shares Alexandria Venture Investments
• Vividion Therapeutics — shares Versant Ventures +1
• IDEAYA Biosciences — shares Alexandria Venture Investments
• Pulmocide — shares SV Health Investors
• Borealis Biosciences — shares Versant Ventures
• TRex Bio — shares Eli Lilly and Company +2
• Triveni Bio — shares Alexandria Venture Investments
• Mersana Therapeutics — shares Eli Lilly and Company
• SixPeaks Bio — shares Versant Ventures
• Nuvaira — shares Versant Ventures
• Deep Genomics — shares Alexandria Venture Investments

Dualitas Therapeutics funding profile · All research reports